tiprankstipranks
Careium AB (SE:CARE)
:CARE
Sweden Market
Want to see SE:CARE full AI Analyst Report?

Careium AB (CARE) AI Stock Analysis

1 Followers

Top Page

SE:CARE

Careium AB

(CARE)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
kr26.00
▲(5.69% Upside)
Action:UpgradedDate:04/24/26
The score is driven primarily by improved fundamentals (profitability turnaround and lower leverage), supported by strong technical momentum (price above key moving averages, positive MACD). The main constraints are recent margin compression and uneven/free-cash-flow softness, while valuation looks reasonable at ~12x earnings but lacks dividend data.
Positive Factors
Sustained Profitability
Careium’s multi-year return to positive profitability (sustained since 2023) indicates the business has restored operating viability. Durable profits support reinvestment in product and service quality, reduce refinancing risk, and improve capacity to fund recurring-service growth over the next 2–6 months.
Negative Factors
Weak Revenue Trend
Revenue slipping ~1.9% signals limited top-line momentum and potential stagnation in selling to municipalities and care providers. Slower revenue growth constrains operating leverage, limits scale benefits from the installed base, and makes margin and cashflow improvements harder to sustain over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Profitability
Careium’s multi-year return to positive profitability (sustained since 2023) indicates the business has restored operating viability. Durable profits support reinvestment in product and service quality, reduce refinancing risk, and improve capacity to fund recurring-service growth over the next 2–6 months.
Read all positive factors

Careium AB (CARE) vs. iShares MSCI Sweden ETF (EWD)

Careium AB Business Overview & Revenue Model

Company Description
Careium AB (Publ) provides technology-enabled care services in Sweden, Norway, the United Kingdom, the Netherlands, and the rest of Europe. It offers social alarms and mobile social alarms; smoke, heat, flood, carbon monoxide, and extreme temperat...
How the Company Makes Money
Careium makes money by selling technology-enabled care solutions and related services to organizations that deliver or fund care. Key revenue streams typically include: (1) Hardware/device sales: revenue from supplying personal alarms and connecte...

Careium AB Financial Statement Overview

Summary
Profitability has recovered and stayed positive since 2023, leverage has improved to a more conservative level, and cash flow is now consistently positive. Offsetting this, net margins have recently compressed (2024 to 2025/TTM) and free cash flow has been volatile with weaker cash conversion (TTM FCF to net income ~0.46).
Income Statement
74
Positive
Balance Sheet
78
Positive
Cash Flow
63
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue866.30M854.10M870.70M824.60M725.10M587.50M
Gross Profit377.70M375.10M373.70M340.50M273.70M240.30M
EBITDA124.50M120.60M150.60M137.90M67.90M65.10M
Net Income33.00M35.80M58.40M37.90M-8.60M4.70M
Balance Sheet
Total Assets1.09B1.09B1.05B961.40M992.10M1.05B
Cash, Cash Equivalents and Short-Term Investments37.90M54.90M31.90M31.50M39.90M142.50M
Total Debt207.80M209.70M196.80M225.30M322.70M292.30M
Total Liabilities394.30M407.40M371.40M361.90M425.50M500.20M
Stockholders Equity698.50M681.50M678.20M599.50M566.60M551.50M
Cash Flow
Free Cash Flow48.30M51.30M36.90M61.90M-87.10M-70.90M
Operating Cash Flow131.60M143.40M92.90M111.90M-21.10M-19.80M
Investing Cash Flow-100.10M-102.20M-56.00M-50.00M-68.70M-163.70M
Financing Cash Flow-31.00M-13.70M-39.60M-69.70M-15.10M291.00M

Careium AB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price24.60
Price Trends
50DMA
20.42
Positive
100DMA
22.58
Positive
200DMA
24.30
Negative
Market Momentum
MACD
0.13
Negative
RSI
70.98
Negative
STOCH
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CARE, the sentiment is Positive. The current price of 24.6 is above the 20-day moving average (MA) of 20.14, above the 50-day MA of 20.42, and above the 200-day MA of 24.30, indicating a neutral trend. The MACD of 0.13 indicates Negative momentum. The RSI at 70.98 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:CARE.

Careium AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
kr1.13B25.242.85%1.25%-13.27%
75
Outperform
kr555.65M10.304.07%17.16%-9.42%
73
Outperform
kr564.37M15.72-0.13%-36.54%
54
Neutral
kr114.76M-30.31-1.58%5.08%47.38%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
48
Neutral
kr111.03M-0.22-45.32%-10.29%60.73%
41
Neutral
kr104.84M-12.0215.14%80.19%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:CARE
Careium AB
23.60
-4.00
-14.49%
SE:LEVEL
Nordic LEVEL Group AB Class B
0.54
-0.06
-10.33%
SE:CNCJO.B
Concejo AB Class B
47.50
13.82
41.05%
SE:IRIS
Irisity AB
0.59
0.29
96.00%
SE:TSEC
Tempest Security AB
10.00
0.22
2.25%
SE:FIRE
Firefly AB
188.50
12.20
6.92%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 24, 2026